EFFECTS OF INTERLEUKIN-1-BETA AND INTERLEUKIN-2 ON AMINO-ACIDS LEVELS IN MOUSE CORTEX AND HIPPOCAMPUS

被引:19
作者
BIANCHI, M
FERRARIO, P
ZONTA, N
PANERAI, AE
机构
[1] Department of Pharmacology, University of Milano, Milano, 20129
关键词
INTERLEUKIN-1; INTERLEUKIN-2; NEUROTRANSMITTER AMINO ACIDS;
D O I
10.1097/00001756-199508000-00023
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
WE measured the levels of glutamine, aspartic acid, glutamic acid and GABA in cortex and hippocampus of mice acutely treated with i.p. human recombinant interleukin-2 (IL-2) or human remombinant interleukin-1 beta (IL-1 beta). Administration of IL-2 (5.0 mu g kg(-1)) induced a slight but statistically significant increase in glutamine concentrations in both brain areas, while similar administration of IL-1 beta (20 mu g kg(-1)) significantly reduced the hippocampal levels of glutamine, glutamic acid and GABA. Our data suggest that brain amino acid pathways are involved in the central modifications induced by IL-1 beta.
引用
收藏
页码:1689 / 1692
页数:4
相关论文
共 25 条
[1]   THE INTERLEUKIN-1-ALPHA, INTERLEUKIN-1-ALPHA, AND INTERLEUKIN-2 DO NOT ACUTELY DISRUPT THE MURINE BLOOD-BRAIN-BARRIER [J].
BANKS, WA ;
KASTIN, AJ .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (04) :629-636
[2]  
BANKS WA, 1991, J PHARMACOL EXP THER, V259, P988
[3]  
BESEDOVSKY HO, 1990, ANN NY ACAD SCI, V594, P214
[4]   INTERLEUKIN-2 ENHANCES SCOPOLAMINE-INDUCED AMNESIA AND HYPERACTIVITY IN THE MOUSE [J].
BIANCHI, M ;
PANERAI, AE .
NEUROREPORT, 1993, 4 (08) :1046-1048
[5]  
BIANCHI M, 1993, COGNITIVE BRAIN RES, V1, P257, DOI 10.1016/0926-6410(93)90009-T
[6]   NMDA RECEPTORS - THEIR ROLE IN LONG-TERM POTENTIATION [J].
COLLINGRIDGE, GL ;
BLISS, TVP .
TRENDS IN NEUROSCIENCES, 1987, 10 (07) :288-293
[7]  
Cooper J. R., 1991, BIOCH BASIS NEUROPHA, P133
[8]   LOCALIZATION OF INTERLEUKIN-1 RECEPTOR MESSENGER-RNA IN MURINE HIPPOCAMPUS [J].
CUNNINGHAM, ET ;
WADA, E ;
CARTER, DB ;
TRACEY, DE ;
BATTEY, JF ;
DESOUZA, EB .
ENDOCRINOLOGY, 1991, 128 (05) :2666-2668
[9]   THE NEURO-ENDOCRINE EFFECTS OF INTERLEUKIN-2 TREATMENT [J].
DENICOFF, KD ;
DURKIN, TM ;
LOTZE, MT ;
QUINLAN, PE ;
DAVIS, CL ;
LISTWAK, SJ ;
ROSENBERG, SA ;
RUBINOW, DR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (02) :402-410
[10]   REDUCTION OF EXPLORATORY-BEHAVIOR BY INTRAPERITONEAL INJECTION OF INTERLEUKIN-1 INVOLVES BRAIN CORTICOTROPIN-RELEASING FACTOR [J].
DUNN, AJ ;
ANTOON, M ;
CHAPMAN, Y .
BRAIN RESEARCH BULLETIN, 1991, 26 (04) :539-542